Predisposing factors for postoperative nausea and vomiting in gynecologic tumor patients
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Support Care Cancer
Abstract
Purpose To evaluate the predictors of postoperative nausea
and vomiting (PONV) in women with gynecologic tumor.
Methods The analysis was based on prospectively collected
data of 82 adult patients with gynecologic tumor, who were
submitted to open surgical treatment and undergoing general
anesthesia. The predictors included were age ≥50 years, non smoker, use of postoperative opioids, mechanical bowel prep aration, intraoperative intravenous hydration (IH) ≥10 mL/kg/
h, and IH in the immediate postoperative, first and second
postoperative days (PO1 and PO2) ≥30 mL/kg. A score with
predictor variables was built. A multiple logistic regression
was fitted. To estimate the discriminating power of the chosen
model, a receiver operating characteristic (ROC) curve was
plotted and the area under the ROC curve (AUC) was calcu lated. Statistical significance was set at p value <0.05 and the
confidence interval at 95 %.
Results The incidence (%) of nausea, vomiting and both, in
the general population, was 36.6, 28.1, 22.0, respectively. The
highest incidences of PONV were found in non-smokers and
in patients who received >30 mL/kg of IH in the PO2. The
results of the adjusted model showed an increased risk of
PONV for each 1-point increase in the score punctuation.
The relative risk was higher than 2.0 for vomiting in all period
and in the PO1. The ROC curve showed great discrimination
of postoperative nausea and vomiting from the proposed score
(AUC >0.75).
Conclusions The study population was at high risk of PONV.
Therefore, institutional guidelines abolishing modificable var iables following temporal evaluation of the effectiveness
should be undertaken.
Description
p. 4661–4667.: tab. p&b.
Citation
CHAVES, Gabriela Villaça; SOUZA, Daiane Spitz de; COSTA, Amine Farias. Predisposing factors for postoperative nausea and vomiting in gynecologic tumor patients. Support Care Cancer, v. 24, p. 4661–4667, 2016.